Quick Answer
Pacira BioSciences, Inc. reported Total Assets of $1.26 billion for fiscal year 2025.
Pacira BioSciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.26B | -18.6% |
| 2024 | $1.55B | -1.3% |
| 2023 | $1.57B | -6.4% |
| 2022 | $1.68B | -19.0% |
| 2021 | $2.08B | +62.8% |
| 2020 | $1.27B | +53.4% |
| 2019 | $831.07M | +20.6% |
| 2018 | $689.35M | +9.7% |
| 2017 | $628.37M | +60.5% |
| 2016 | $391.47M | +1.0% |
| 2015 | $387.74M | +18.9% |
| 2014 | $326.07M | +92.0% |
| 2013 | $169.82M | +51.6% |
| 2012 | $112.05M | -1.3% |
| 2011 | $113.49M | +70.5% |
| 2010 | $66.56M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.30B | -14.7% | -15.6% |
| June 30, 2025 | $1.54B | -6.7% | -3.1% |
| March 31, 2025 | $1.59B | +0.2% | +2.1% |
| December 31, 2024 | $1.55B | -1.3% | +2.1% |
| September 30, 2024 | $1.52B | -0.8% | -7.6% |
| June 30, 2024 | $1.65B | +6.8% | +4.0% |
| March 31, 2024 | $1.58B | +3.9% | +0.6% |
| December 31, 2023 | $1.57B | -6.4% | +2.6% |
- Pacira BioSciences, Inc. showed a decrease of -18.6% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Pacira BioSciences, Inc.’s total assets has grown by 1800.4% (from $66.56 million to $1.26 billion).
- The most recent figure is from Pacira BioSciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: